Relapsed
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies (NCT03881774) | Henan Cancer Hospital | 2019-02-27 |
| CD19/20 Bispecific Nanobody-derived CAR-T Cells in B Cell Lymphoma (NCT03881761) | Henan Cancer Hospital | 2019-02-01 |
| Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory Lymphomas (NCT03179930) | Memorial Sloan Kettering Cancer Center | 2017-06-07 |
| Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia (NCT02677064) | Memorial Sloan Kettering Cancer Center | 2016-02-01 |
Track Relapsed automatically
Every clearance here is in the API, with alerts when new ones post.